Editas: Q1 Earnings Snapshot

Published: 2026-05-05 07:17:08 ET EDIT

Published on 05/05/2026 at 07:17 am EDT

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Tuesday reported a loss of $25 million in its first quarter.

The Cambridge, Massachusetts-based company said it had a loss of 26 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.

The genome editing company posted revenue of $2.8 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $8.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News